Published in
BioMed Central, Journal of Experimental and Clinical Cancer Research, 1(36), 2017
DOI: 10.1186/s13046-017-0592-3
Links
Tools
Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer
Journal article published in 2017 by
Bernhard Englinger 
,
Sebastian Kallus,
Julia Senkiv,
Daniela Heilos,
Lisa Gabler,
Sushilla van Schoonhoven,
Alessio Terenzi,
Patrick Moser,
Christine Pirker,
Gerald Timelthaler,
Walter Jäger,
Christian R. Kowol,
Petra Heffeter,
Michael Grusch,
Walter Berger
,
Sebastian Kallus,
Julia Senkiv,
Daniela Heilos,
Lisa Gabler,
Sushilla van Schoonhoven,
Alessio Terenzi,
Patrick Moser,
Christine Pirker,
Gerald Timelthaler,
Walter Jäger,
Christian R. Kowol,
Petra Heffeter,
Michael Grusch,
Walter Berger
This paper is made freely available by the publisher.
Full text: Download
Data provided by 